NCT03601338View on ClinicalTrials.gov

Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

December 1, 2018

Study Completion Date

December 6, 2018

Conditions
Unexplained Stillbirth
Interventions
DRUG

Bemiparin

second generation low molecular weight Heparin

OTHER

multivitamins and routine antenatal follow up

multivitamins and routine antenatal follow up

Trial Locations (1)

44001

Hawler Medical University, Erbil

All Listed Sponsors
lead

Hawler Medical University

OTHER

NCT03601338 - Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths | Biotech Hunter | Biotech Hunter